Search

everythinglearnresearchcommunity

for

Search:↓

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Finasteride side effects in young men may be linked to specific gene variations.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Finasteride exposure affects gene expression and anogenital distance in male rat fetuses.

Medications for PCOS don't seem to raise heart disease risk.

AR gene variations don't affect aging markers in men.

Iron deficiency is linked to female pattern hair loss.

Individualized treatment improves symptoms and quality of life for women with PCOS.

PCOS and lifestyle choices like diet and hair removal methods play a key role in moderate hirsutism.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Lower ghrelin levels and certain gene variations may increase acne risk.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Researchers developed a reliable way to measure hormones in urine, showing that a baldness treatment doesn't change hormone levels.